ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kentucky » Neurology

Top Neurology Prescribers in Kentucky

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JIANHUA ZHU M.D.

Neurology

7,130

$1.78M

695
388 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

2%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$249
Average prescription price

Avg: $208

SATISH SHAH MD

Neurology

5,906

$1.11M

627
395 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

2%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 23%

$188
Average prescription price

Avg: $208

DAVID BLAKE MD

Neurology

5,794

$2.21M

642
474 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 23%

$381
Average prescription price

Avg: $208

MAUREEN LI MD

Neurology

5,639

$1.06M

543
373 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$189
Average prescription price

Avg: $208

SUJATA GUTTI MD

Neurology

5,564

$1.03M

539
210 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$186
Average prescription price

Avg: $208

CRAIG KNOX MD

Neurology

5,510

$783K

495
336 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$142
Average prescription price

Avg: $208

LARRY GROSS MD

Neurology

5,478

$642K

285
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$117
Average prescription price

Avg: $208

JASON MECKLER MD

Neurology

5,264

$1.33M

362
158 are 65+

16%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 23%

$253
Average prescription price

Avg: $208

NAVEED AHMED M.D

Neurology

4,820

$496K

562
274 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$103
Average prescription price

Avg: $208

ROY MECKLER MD

Neurology

4,712

$2.7M

406
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 23%

$573
Average prescription price

Avg: $208

VICTOR ANGELES MD

Neurology

4,559

$358K

339
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 5%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

10%
prescriptions for brand name drugs

Avg: 23%

$79
Average prescription price

Avg: $208

RUKMAIAH BHUPALAM MD

Neurology

4,465

$616K

497
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 23%

$138
Average prescription price

Avg: $208

JAMES METCALF MD

Neurology

4,292

$1.02M

320
183 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$238
Average prescription price

Avg: $208

SYED RAZA M.D.

Neurology

4,243

$428K

313
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 5%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$101
Average prescription price

Avg: $208

WESLEY CHOU M.D.

Neurology

4,190

$473K

396
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 23%

$113
Average prescription price

Avg: $208

ALAM KHAN MD

Neurology

4,189

$676K

481
244 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$161
Average prescription price

Avg: $208

JAMES WINKLEY M.D.

Neurology

4,160

$1.43M

427
268 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$344
Average prescription price

Avg: $208

NAGHMA MUFTI M.D.

Neurology

4,050

$1.08M

496
243 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$267
Average prescription price

Avg: $208

ALEXANDER TIKHTMAN MD

Neurology

3,958

$510K

385
204 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 23%

$129
Average prescription price

Avg: $208

NICOLE EVERMAN M.D.

Neurology

3,936

$837K

522
345 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 23%

$213
Average prescription price

Avg: $208

ARDEN ACOB MD

Neurology

3,903

$547K

365
141 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

30%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$140
Average prescription price

Avg: $208

P. SCOTT BECKER M.D.

Neurology

3,880

$1.02M

347
234 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 23%

$262
Average prescription price

Avg: $208

ROBERT TILLETT MD

Neurology

3,839

$2.5M

291
129 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 23%

$652
Average prescription price

Avg: $208

PATRICK LEUNG M.D.

Neurology

3,785

$553K

394
264 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 5%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 23%

$146
Average prescription price

Avg: $208

ENAWGAW MEHARI MD

Neurology

3,714

$482K

355
177 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$130
Average prescription price

Avg: $208

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank